Is IDEXX Laboratories a good investment? Analyzing its consistent growth, innovative products, and international expansion ...

Veterinary diagnostics specialist Idexx Laboratories (NASDAQ:IDXX) reported fourth-quarter earnings on Monday, Feb. 3, that topped analysts' consensus top- and bottom-line estimates. Revenue for ...

Idexx Laboratories (IDXX) came out with quarterly earnings of $2.62 per share, beating the Zacks Consensus Estimate of $2.40 per share. This compares to earnings of $2.32 per share a year ago.

In its fourth quarter 2024 investor letter, Baron Asset Fund emphasized stocks such as IDEXX Laboratories, Inc. (NASDAQ:IDXX). IDEXX Laboratories, Inc. (NASDAQ:IDXX) develops, manufactures ...

In a new SEC filing on February 11, it was revealed that Fennell, Executive Vice President at IDEXX Laboratories IDXX, executed a significant exercise of company stock options. What Happened ...

Piper Sandler analyst David Westenberg maintained a Hold rating on Idexx Laboratories (IDXX – Research Report) today and set a price target of $510.00. The company’s shares closed last Friday ...

In its fourth quarter 2024 investor letter, Conestoga Capital Advisors emphasized stocks such as IDEXX Laboratories, Inc. (NASDAQ:IDXX). IDEXX Laboratories, Inc. (NASDAQ:IDXX) develops ...

IDEXX Laboratories Inc (NASDAQ:IDXX) reported fourth-quarter adjusted EPS of $2.53, up 10% year-over-year, beating the consensus of $2.40. The pet healthcare company reported sales of $954.3 ...

Across the recent three months, 4 analysts have shared their insights on IDEXX Laboratories (NASDAQ:IDXX), expressing a variety of opinions spanning from bullish to bearish. The table below ...